These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22403079)

  • 1. The PTEN and Myotubularin phosphoinositide 3-phosphatases: linking lipid signalling to human disease.
    Davies EM; Sheffield DA; Tibarewal P; Fedele CG; Mitchell CA; Leslie NR
    Subcell Biochem; 2012; 58():281-336. PubMed ID: 22403079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol-3,5-bisphosphate: metabolism and physiological functions.
    Takasuga S; Sasaki T
    J Biochem; 2013 Sep; 154(3):211-8. PubMed ID: 23857703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WANTED - Dead or alive: Myotubularins, a large disease-associated protein family.
    Raess MA; Friant S; Cowling BS; Laporte J
    Adv Biol Regul; 2017 Jan; 63():49-58. PubMed ID: 27666502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure and regulation of myotubularin phosphatases.
    Begley MJ; Dixon JE
    Curr Opin Struct Biol; 2005 Dec; 15(6):614-20. PubMed ID: 16289848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myotubularin phosphatases: policing 3-phosphoinositides.
    Robinson FL; Dixon JE
    Trends Cell Biol; 2006 Aug; 16(8):403-12. PubMed ID: 16828287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies.
    Vaccari I; Dina G; Tronchère H; Kaufman E; Chicanne G; Cerri F; Wrabetz L; Payrastre B; Quattrini A; Weisman LS; Meisler MH; Bolino A
    PLoS Genet; 2011 Oct; 7(10):e1002319. PubMed ID: 22028665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotubularin regulates Akt-dependent survival signaling via phosphatidylinositol 3-phosphate.
    Razidlo GL; Katafiasz D; Taylor GS
    J Biol Chem; 2011 Jun; 286(22):20005-19. PubMed ID: 21478156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease.
    Kim SA; Taylor GS; Torgersen KM; Dixon JE
    J Biol Chem; 2002 Feb; 277(6):4526-31. PubMed ID: 11733541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between myotubularins and Ca
    Dai N; Groenendyk J; Michalak M
    Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119739. PubMed ID: 38710289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myotubularin family: from genetic disease to phosphoinositide metabolism.
    Laporte J; Blondeau F; Buj-Bello A; Mandel JL
    Trends Genet; 2001 Apr; 17(4):221-8. PubMed ID: 11275328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
    Maehama T; Dixon JE
    J Biol Chem; 1998 May; 273(22):13375-8. PubMed ID: 9593664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway.
    Blondeau F; Laporte J; Bodin S; Superti-Furga G; Payrastre B; Mandel JL
    Hum Mol Genet; 2000 Sep; 9(15):2223-9. PubMed ID: 11001925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotubularin phosphoinositide phosphatases in human diseases.
    Amoasii L; Hnia K; Laporte J
    Curr Top Microbiol Immunol; 2012; 362():209-33. PubMed ID: 23086420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate.
    Taylor GS; Maehama T; Dixon JE
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8910-5. PubMed ID: 10900271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome.
    Begley MJ; Taylor GS; Kim SA; Veine DM; Dixon JE; Stuckey JA
    Mol Cell; 2003 Dec; 12(6):1391-402. PubMed ID: 14690594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases.
    Schaletzky J; Dove SK; Short B; Lorenzo O; Clague MJ; Barr FA
    Curr Biol; 2003 Mar; 13(6):504-9. PubMed ID: 12646134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phosphoinositide conversion mechanism for exit from endosomes.
    Ketel K; Krauss M; Nicot AS; Puchkov D; Wieffer M; Müller R; Subramanian D; Schultz C; Laporte J; Haucke V
    Nature; 2016 Jan; 529(7586):408-12. PubMed ID: 26760201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice.
    Robinson FL; Niesman IR; Beiswenger KK; Dixon JE
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4916-21. PubMed ID: 18349142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CMT4B disease-causing phosphatases Mtmr2 and Mtmr13 localize to the Schwann cell cytoplasm and endomembrane compartments, where they depend upon each other to achieve wild-type levels of protein expression.
    Ng AA; Logan AM; Schmidt EJ; Robinson FL
    Hum Mol Genet; 2013 Apr; 22(8):1493-506. PubMed ID: 23297362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.